0000009326-26-000018
SEC filingBalchem delivered solid first-quarter results, with revenue growth of 8.1% and gross profit expanding 14.6% driven by higher sales and favorable mix. Profitability gains were partially offset by increased operating expenses, primarily related to compensation and professional services.
Balchem Corporation reported a strong start to fiscal year 2026, with total revenue reaching $270.7 million, an 8.1% increase compared to the prior year period. This top-line growth was driven by higher sales volumes and a favorable product mix, which collectively supported the period's performance.
Gross profit for the quarter was $101.1 million, representing a 14.6% increase over the comparable quarter. The improvement in gross profit reflects the benefits of higher sales and favorable mix, although these gains were partially offset by increased manufacturing input costs. Consequently, the gross margin for the quarter stood at 37.3%.
Operating income rose 9.0% to $55.6 million. The increase in profitability was tempered by a rise in operating expenses, which management attributed primarily to higher compensation-related costs and increased professional services fees. These investments in personnel and services reflect the company's ongoing operational needs.
Net income for the quarter was $40.3 million, or $1.25 per diluted share, compared to $37.1 million, or $1.13 per diluted share, in the prior year period. This represents an 8.7% increase in net income and a 10.6% increase in diluted earnings per share.
Net cash provided by operating activities increased to $40.1 million for the quarter, up from $36.5 million in the same period last year. Management indicated that they expect operations to continue generating sufficient cash flow to fund working capital requirements and necessary capital investments. The company maintains a positive outlook on its ability to fund its operational commitments and strategic initiatives through its internal cash generation.